Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies

Current licensed and commercially available prophylactic human papillomavirus (HPV) vaccines (Cervarix and quadrivalent/nine valents Gardasil) are based on major capsid protein L1 virus-like particles (VLPs) production which are expensive and type specific. Minor capsid L2-RG1 linear epitope (17-36)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Res Pharm Sci
Main Authors: Khiavi, Farhad Motavalli, Arashkia, Arash, Nasimi, Maryam, Mahdavi, Mehdi, Golkar, Majid, Roohvand, Farzin, Azadmanesh, Kayhan
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566000/
https://ncbi.nlm.nih.gov/pubmed/28855937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-5362.212043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados